Clinical Trial Update: Trial to Evaluate PRO 2000/5 Gels for the Prevention of Vaginally Acquired HIV Infection [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating PRO 2000/5 Gel for preventing vaginal HIV infection has completed. Endo Pharmaceuticals sponsored the trial.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• PRO 2000/5 Gel (PRO 2000)

Snippet

Sponsor: Endo Pharmaceuticals | Conditions: HIV Infections, Gonorrhea | Phase 3 | Status: COMPLETED